INTECH Investment Management’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-3,560
Closed -$200K 2533
2024
Q4
$200K Sell
3,560
-8,426
-70% -$524K ﹤0.01% 2033
2024
Q3
$816K Buy
11,986
+402
+3% +$22.7K 0.01% 931
2024
Q2
$489K Buy
11,584
+116
+1% +$6.38K 0.01% 814
2024
Q1
$792K Sell
11,468
-186
-2% -$11.8K 0.01% 488
2023
Q4
$862K Sell
11,654
-1,410
-11% -$92.4K 0.01% 453
2023
Q3
$891K Buy
13,064
+5,124
+65% +$435K 0.01% 460
2023
Q2
$746K Sell
7,940
-5,504
-41% -$429K 0.01% 523
2023
Q1
$912K Sell
13,444
-675
-5% -$43.4K 0.01% 530
2022
Q4
$699K Buy
14,119
+569
+4% +$23.2K 0.01% 567
2022
Q3
$440K Hold
13,550
﹤0.01% 605
2022
Q2
$534K Buy
+13,550
New +$725K ﹤0.01% 602

Other funds holding EXAS

INTECH Investment Management's EXAS Position: Q1 2025 in Review

INTECH Investment Management sold out of Exact Sciences (EXAS) in Q1 2025, closing a stake of 3,560 shares — an estimated $200K sold.

INTECH Investment Management first reported a position in EXAS in Q2 2022 and held it in 11 quarters. The position peaked at $912K in Q1 2023. 558 funds tracked by Wall St. Rank hold EXAS as of Q1 2025.

  • INTECH Investment Management reported no remaining Exact Sciences position as of Q1 2025 after selling out during the quarter.
  • INTECH Investment Management sold 3,560 Exact Sciences shares in Q1 2025, an estimated $200K.
  • INTECH Investment Management first reported a position in Exact Sciences in Q2 2022 and held it in 11 quarters.
  • INTECH Investment Management's Exact Sciences position peaked at $912K in Q1 2023.
  • 558 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2025.

Based on INTECH Investment Management's 13F filing for Q1 2025, filed 20 May 2025.